UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication ...

A recent study emphasizes the connection between inflammation and depression, offering a new perspective that challenges ...

For individuals struggling with both depression and obesity, a new Stanford Medicine study says yes—when the therapy is the ...

Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional ...

Bright light therapy, a standard treatment for seasonal depression, may also help people who experience depression year-round ...

Chronic pain and treatment-resistant depression — both impact millions of people, both can be debilitating and both can leave people feeling hopeless.

Phase II results for Cybin’s psilocin therapy showed remission rates of 71%, but just eight patients made it to the 12-month ...

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help ...

In recent years, their importance has started to be questioned as new, successful treatments ... patients appear to be more at risk of depression. If the drug doesn’t make a difference to ...

“FDA cleared transcranial magnetic stimulation is a proven and effective treatment with minimal side effects. We designed the Inspire to enable both experienced TMS providers as well as those who are ...

With nearly 20 percent of U.S. adults affected by depression, the prevalence of this mental health condition drives many to ...